-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $277 at RBC Capital
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised at TD Cowen Following 'Nice Topline Beat And Raise'
-
-
-
-
-
-
-
Jazz Pharmaceuticals presents Xywav sleep disorder data at SLEEP 2026 conference
-
-
-
-
-
-
-
UBS Upgrades Jazz Pharmaceuticals (JAZZ) to Buy
-
-
-
-
-
-
-
Barclays Reiterates Overweight Rating on Jazz Pharmaceuticals (JAZZ)
-
-
-
-
-
-
-
Jazz Pharmaceuticals names Thomas Riga as Chief Business Officer
-
-
-
-
-
-
-
Jazz Pharmaceuticals to present Epidiolex data at epilepsy conference
-
472,583 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


